Skip to main content

Main menu

  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us

Clinical Medicine Journal

  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

User menu

  • Log in

Search

  • Advanced search
RCP Journals
Home
  • Log in
  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us
Advanced

Clinical Medicine Journal

clinmedicine Logo
  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

Role of Taxotere in metastatic castration-resistant prostate cancer in Sudanese patients and the effective number of cycle and dose (2013–2017)

Ehssan Mohamed El-Nazir, Yousra Abdelmoniem Suleiman, Rogia Omer Ibrahim Alameen, Khalda Esmaiel Adam Abaker, Rayan Mohammed Yassin Mohammed, Anfal Abd-Alrhman Al-Rayah, Thowiba Abd-Alrahman Alzain, Alaa Albukhari Alrayah, Sujood Abd Elmoneim Mohammed, Mawahib Ahmed Elawad Abu Elgasim and Roaa Osman Ahmed Babker
Download PDF
DOI: https://doi.org/10.7861/clinmedicine.19-3s-s31
Clin Med June 2019
Ehssan Mohamed El-Nazir
Omdurman Islamic University, Sudan, Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yousra Abdelmoniem Suleiman
Omdurman Islamic University, Sudan, Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rogia Omer Ibrahim Alameen
Omdurman Islamic University, Sudan, Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Khalda Esmaiel Adam Abaker
Omdurman Islamic University, Sudan, Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rayan Mohammed Yassin Mohammed
Omdurman Islamic University, Sudan, Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anfal Abd-Alrhman Al-Rayah
Omdurman Islamic University, Sudan, Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thowiba Abd-Alrahman Alzain
Omdurman Islamic University, Sudan, Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alaa Albukhari Alrayah
Omdurman Islamic University, Sudan, Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sujood Abd Elmoneim Mohammed
Omdurman Islamic University, Sudan, Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mawahib Ahmed Elawad Abu Elgasim
Omdurman Islamic University, Sudan, Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roaa Osman Ahmed Babker
Omdurman Islamic University, Sudan, Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Background

Prostate cancer remains the most common cancer in men worldwide and in Sudanese people. The initial treatment of choice for prostate cancer is androgen deprivation. If resistant to treatment, this leads to a state termed metastatic castration-resistant prostate cancer (mCRPC) which leads to the use of docetaxel (Taxotere) which has been a mainstay of therapy for patients with mCRPC.

Objectives

  • To evaluate the benefit of docetaxel in patients with mCRPC after initial good response to first-line hormonal therapy.

  • To determine the effective number of cycles and doses of docetaxel.

Methods

  • Study design; retrospective study (duration, 2013–2017).

  • Area; The Radiation and Isotopes Centre of Khartoum (RICK).

  • Population; mCRPC in RICK.

  • Inclusion criteria; any prostatic cancer patient who became castration-resistant and was receiving docetaxel therapy.

  • Exclusion criteria; prostatic cancer patients not castration-resistant and not on docetaxel therapy.

  • Data collection; RICK record.

  • Procedure; patient files, sample size 60 patients.

  • Permission; from Ministry of Health and from RICK.

Results and conclusion

To determine the optimal number of cycles of docetaxel for mCRPC, we retrospectively collected data from 60 patients receiving varying numbers of docetaxel plus prednisolone and analysed the clinical outcomes including performance status, prostate-specific antigen (PSA) response and pain. According to this study we found that docetaxel has an effective role in the treatment of mCRPC patients with an optimal number of 6–8 cycles every 3 weeks and with a dose of 75 mg.

Conflict of interest statement

None declared.

  • © Royal College of Physicians 2019. All rights reserved.
Back to top
Previous articleNext article

Article Tools

Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Role of Taxotere in metastatic castration-resistant prostate cancer in Sudanese patients and the effective number of cycle and dose (2013–2017)
Ehssan Mohamed El-Nazir, Yousra Abdelmoniem Suleiman, Rogia Omer Ibrahim Alameen, Khalda Esmaiel Adam Abaker, Rayan Mohammed Yassin Mohammed, Anfal Abd-Alrhman Al-Rayah, Thowiba Abd-Alrahman Alzain, Alaa Albukhari Alrayah, Sujood Abd Elmoneim Mohammed, Mawahib Ahmed Elawad Abu Elgasim, Roaa Osman Ahmed Babker
Clinical Medicine Jun 2019, 19 (Suppl 3) s31; DOI: 10.7861/clinmedicine.19-3s-s31

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Role of Taxotere in metastatic castration-resistant prostate cancer in Sudanese patients and the effective number of cycle and dose (2013–2017)
Ehssan Mohamed El-Nazir, Yousra Abdelmoniem Suleiman, Rogia Omer Ibrahim Alameen, Khalda Esmaiel Adam Abaker, Rayan Mohammed Yassin Mohammed, Anfal Abd-Alrhman Al-Rayah, Thowiba Abd-Alrahman Alzain, Alaa Albukhari Alrayah, Sujood Abd Elmoneim Mohammed, Mawahib Ahmed Elawad Abu Elgasim, Roaa Osman Ahmed Babker
Clinical Medicine Jun 2019, 19 (Suppl 3) s31; DOI: 10.7861/clinmedicine.19-3s-s31
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Background
    • Objectives
    • Methods
    • Results and conclusion
    • Conflict of interest statement
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • An experimental series investigating the factors that influence the effect of hyperinsulinaemic euglycaemia on myocardial blood flow reserve
  • Specialist emergency care and COPD outcomes
  • A multi cross-site survey on Trichomonas vaginalis diagnosis in the Barts Health NHS Trust, London
Show more Clinical

Similar Articles

Navigate this Journal

  • Journal Home
  • Current Issue
  • Ahead of Print
  • Archive

Related Links

  • ClinMed - Home
  • FHJ - Home
clinmedicine Footer Logo
  • Home
  • Journals
  • Contact us
  • Advertise
HighWire Press, Inc.

Follow Us:

  • Follow HighWire Origins on Twitter
  • Visit HighWire Origins on Facebook

Copyright © 2021 by the Royal College of Physicians